Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


29 Ekim 2021, Cuma, 00:08 Notes from the Field: Update on Excess Deaths Associated with the COVID-19 Pandemic - United States, January 26, 2020-February 27, 2021
This report provides an update on excess deaths in the United States associated with the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420529


29 Ekim 2021, Cuma, 00:08 Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021
mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection was 90% for full immunization (≥14 days after second dose) and 80% for partial immunization (≥14 days after first dose but before second dose) in real-world conditions.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=419354


29 Ekim 2021, Cuma, 00:08 Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic - United States, August 2020-February 2021
From August 2020-February 2021, adults with recent symptoms of an anxiety or depressive disorder increased from 36% to 42%. Increases were largest among adults 18-29 years and those with less than a high school education.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=419353


29 Ekim 2021, Cuma, 00:08 The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020
This report describes the interim recommendation made by the Advisory Committee on Immunization Practices on December 19, 2020, for use of the Moderna COVID-19 vaccine in persons aged ≥18 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=415166


29 Ekim 2021, Cuma, 00:08 The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020
This report describes the interim recommendation made by the Advisory Committee on Immunization Practices on December 12, 2020, for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=414100


29 Ekim 2021, Cuma, 00:08 Estimated Resource Costs for Implementation of CDC's Recommended COVID-19 Mitigation Strategies in Pre-Kindergarten through Grade 12 Public Schools - United States, 2020-21 School Year
This report describes the cost information necessary to budget and prioritize school resources during the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=413949


29 Ekim 2021, Cuma, 00:08 Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic - Nine States, Nigeria, March 31, 2019-September 30, 2020
This report describes a program that increased the number of persons with HIV infections who initiated antiretroviral therapy before and during the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418930


29 Ekim 2021, Cuma, 00:08 Health Center Testing for SARS-CoV-2 During the COVID-19 Pandemic - United States, June 5-October 2, 2020
This report describes COVID-19 response at health centers funded by the Health Resources and Services Administration.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=414703


29 Ekim 2021, Cuma, 00:08 Telehealth Practice Among Health Centers During the COVID-19 Pandemic - United States, July 11-17, 2020
This report describes telehealth services provided at health centers during the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=414704


29 Ekim 2021, Cuma, 00:08 COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons - United States, December 14, 2020−February 14, 2021
This report describes persons who received both doses of a two-dose COVID-19 vaccination series and the interval between the first and second dose among those who were vaccinated.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418592